Health Systems Trust is a dynamic, not-for-profit organisation that supports the development of an equitable and comprehensive health system for the provision of quality health care in South and southern Africa.
Health Systems Trust (HST) wishes to appoint Clinical Mentors to strengthen the clinical services in each district supported by the South African Sustainable Response to HIV and AIDS (SA SURE) project. SA SURE aims to strengthen local capacity to provide sustainable HIV and TB-related care and treatment services. The number of posts available for each district is listed below. This is a contract position linked to the duration of the project.
There is a big hole in the middle of South Africa’s HIV treatment programme that is undermining government’s remarkable achievements since 2009, when AIDS denialist President Thabo Mbeki was kicked out.
This hole is called medicine stock-outs. It is caused mainly by poor management, and no matter how good our national programme and health minister are, unless the implementers – the provinces – can improve health service delivery, we will not only fail to overcome HIV but we stand to develop a monster called drug-resistant HIV.
Ahead of World AIDS Day 2013, leading HIV/AIDS researchers in Durban have urged society to focus on insights, innovation and integrity in the journey into an HIV-free future – and to put people at the centre of health services.
Policy experts, specialists and activists have joined together to call for more action to provide treatment, care and support for children with cancer in African countries.Their plea has been echoed by a Sowetan father, who lost his daughter to cancer, and is at the forefront of raising awareness of childhood cancer in South Africa, as well as Ghanaian actor and celebrity,Kwaku Sintim-Misa, also known as "KSM".
They were speaking at theWorld Cancer Leaders Summit in Cape Town, at an event jointly hosted by the International Society of Paediatric Oncology (SIOP) and the Paris-based Sanofi Espoir Foundation (SEF).
THE government’s policy on intellectual property (IP), currently under discussion, would seek to strike a balance between the needs of public health and the interests of innovative pharmaceutical companies, Trade and Industry Minister Rob Davies said on Tuesday.
His department released a draft national policy on intellectual for public comment on September 4. While the policy is wide-ranging, one of the areas that has come in for closest public attention is that of health, as activists see the policy drafting process as an opportunity to lobby for measures they believe will lower the price of medicines.
A Cape Town survivor of extensively drug-resistant tuberculosis has taken her campaign for better access to testing and treatment from her hometown of Khayelitsha to Paris and beyond.
In August, 23-year-old Phumeza Tisile beat the odds and became one of only a few hundred South African who beat extensively drug-resistant tuberculosis (XDR-TB) each year. After an almost three-year battle with XDR-TB, Tisile has helped launch a campaign for better access to drug-resistant TB (DR-TB) testing and treatment.
In the first of two linked posts, Mike Frick of Treatment Action Group (TAG) and Audrey Zhang of Harvard College argue that patient-centered approaches in treatment for drug-resistant and drug-sensitive tuberculosis are needed.
New research has shown that rapid GeneXpert tuberculosis (TB) test improves access to TB diagnosis and treatment, and may be ready for South African clinics.
Conducted in part by the University of Cape Town (UCT), the study looked at whether it was possible for nurses – instead of laboratory technicians – to administer the test in clinics in four countries, South Africa, Zimbabwe, Zambia and Tanzania.
South African researchers have thrown their weight behind the first ever global action plan specifically targeted for children with tuberculosis (TB), in the hope of bringing down the country’s extremely high childhood TB rate.
About 45,000 children in South Africa get TB every year, while many more go undiagnosed or are not reported, says Professor Anneke Hesseling, director of the Paediatric TB Research Programme at the Desmond Tutu TB Centre at Stellenbosch University.